Publications by authors named "V N Azger Dusthackeer"

Claim this Profile
B
Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents.
Yedukondalu Nalli, Sanju Singh, Apexa Gajjar, Balasubramanian Mahizhaveni, Vijayan Nynar Azger Dusthackeer

Lett Appl Microbiol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance.
Ramalingam Peraman, Sathish Kumar Sure, V N Azger Dusthackeer, Naresh Babu Chilamakuru, Padmanabha Reddy Yiragamreddy

Futur J Pharm Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine.
Pasupathy Saravanan, V N Azger Dusthackeer, R S Rajmani, B Mahizhaveni, Christy R Nirmal

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
Uttam B Karale, Vagolu Siva Krishna, E Vamshi Krishna, Amit S Choudhari, Manjulika Shukla, V N Azger Dusthackeer

Eur J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Vitthal B Makane, Vagolu Siva Krishna, E Vamshi Krishna, Manjulika Shukla, B Mahizhaveni, V N Azger Dusthackeer

Eur J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis